Healthcare provider profile · identity verified

Hemant Shah, MD

Allopathic & Osteopathic Physicians|Internal Medicine|Geriatric Medicine · HOLIDAY, FL · NPI 1295743508

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Hemant Shah, MD received $138.99 in general payments during 2025 across 5 reported records.

GENZYME CORPORATION accounted for 36.6% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 3 associated products.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$138.99

5 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
GENZYME CORPORATION	Unresolved — no canonical attribution shown	$50.92	36.6%	1	2025
VERTEX PHARMACEUTICALS INCORPORATED	Unresolved — no canonical attribution shown	$45.11	32.5%	2	2025
Collegium Pharmaceutical, Inc.	Unresolved — no canonical attribution shown	$22.83	16.4%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$20.13	14.5%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$138.99	5

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
JOURNAVX Normalized: journavx	Drug	VERTEX PHARMACEUTICALS INCORPORATED	$45.11	2	2025
Source payment records 2025-07-16 · VERTEX PHARMACEUTICALS INCORPORATED · $25.93 · Open Payments source 2025-11-17 · VERTEX PHARMACEUTICALS INCORPORATED · $19.18 · Open Payments source
Belbuca Normalized: belbuca	Drug	Collegium Pharmaceutical, Inc.	$22.83	1	2025
Source payment records 2025-07-24 · Collegium Pharmaceutical, Inc. · $22.83 · Open Payments source
The Cologuard Plus Collection Kit Normalized: the cologuard plus collection kit	Device	Exact Sciences Corporation	$20.13	1	2025
Source payment records 2025-06-25 · Exact Sciences Corporation · $20.13 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	334	104
Meloxicam	Meloxicam	277	75
Losartan Potassium	Losartan Potassium	269	78
Lisinopril	Lisinopril	195	55
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	193	42
Clonazepam	Clonazepam	166	39
Metformin Hcl	Metformin Hcl	155	43
Levothyroxine Sodium	Levothyroxine Sodium	149	38
Tamsulosin Hcl	Tamsulosin Hcl	149	39
Metoprolol Tartrate	Metoprolol Tartrate	147	47
Furosemide	Furosemide	143	49
Metoprolol Succinate	Metoprolol Succinate	140	40
Gabapentin	Gabapentin	139	33
Methylprednisolone	Methylprednisolone	139	73
Amlodipine Besylate	Amlodipine Besylate	135	41
Pantoprazole Sodium	Pantoprazole Sodium	134	45
Baclofen	Baclofen	132	50
Amoxicillin	Amoxicillin	116	63
Simvastatin	Simvastatin	115	31
Omeprazole	Omeprazole	108	35
Trazodone Hcl	Trazodone Hcl	105	36
Albuterol Sulfate Hfa	Albuterol Sulfate	103	30
Clopidogrel	Clopidogrel Bisulfate	99	30
Topiramate	Topiramate	96	29
Tramadol Hcl-Acetaminophen	Tramadol Hcl/Acetaminophen	87	27
Rosuvastatin Calcium	Rosuvastatin Calcium	86	22
Escitalopram Oxalate	Escitalopram Oxalate	85	25
Ibuprofen	Ibuprofen	83	28
Pentoxifylline	Pentoxifylline	82	25
Potassium Chloride	Potassium Chloride	80	27
Montelukast Sodium	Montelukast Sodium	78	25
Finasteride	Finasteride	72	21
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	71	18
Tramadol Hcl	Tramadol Hcl	68	14
Oxybutynin Chloride Er	Oxybutynin Chloride	67	17
Ezetimibe	Ezetimibe	65	17
Prednisone	Prednisone	64	22
Clonidine Hcl	Clonidine Hcl	61	17
Fluticasone Propionate	Fluticasone Propionate	61	25
Pioglitazone Hcl	Pioglitazone Hcl	61	22
Alprazolam	Alprazolam	60	11
Isosorbide Mononitrate Er	Isosorbide Mononitrate	58	18
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	56	11
Celecoxib	Celecoxib	52	14
Ibandronate Sodium	Ibandronate Sodium	51	14
Lorazepam	Lorazepam	51	11
Zolpidem Tartrate	Zolpidem Tartrate	51	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	49	35
Glimepiride	Glimepiride	49	13
Alendronate Sodium	Alendronate Sodium	48	16
Mupirocin	Mupirocin	48	30
Allopurinol	Allopurinol	42	suppressed
Buspirone Hcl	Buspirone Hcl	42	14
Ropinirole Hcl	Ropinirole Hcl	42	suppressed
Sucralfate	Sucralfate	42	14
Enalapril Maleate	Enalapril Maleate	41	11
Tizanidine Hcl	Tizanidine Hcl	41	13
Azithromycin	Azithromycin	40	27
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	39	suppressed
Metformin Hcl Er	Metformin Hcl	39	11
Duloxetine Hcl	Duloxetine Hcl	37	13
Donepezil Hcl	Donepezil Hcl	36	13
Fenofibrate	Fenofibrate	36	suppressed
Citalopram Hbr	Citalopram Hydrobromide	34	suppressed
Testosterone Cypionate	Testosterone Cypionate	33	11
Ozempic	Semaglutide	30	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Metolazone	Metolazone	29	suppressed
Sildenafil Citrate	Sildenafil Citrate	29	11
Atenolol	Atenolol	28	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	28	11
Oxycodone Hcl	Oxycodone Hcl	28	suppressed
Gemfibrozil	Gemfibrozil	27	suppressed
Metronidazole	Metronidazole	27	19
Nitroglycerin	Nitroglycerin	26	16
Spironolactone	Spironolactone	26	suppressed
Carvedilol	Carvedilol	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	24	suppressed
Glipizide Er	Glipizide	24	suppressed
Novolin N	Insulin Nph Human Isophane	24	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	24	suppressed
Cephalexin	Cephalexin	22	12
Fluoxetine Hcl	Fluoxetine Hcl	22	suppressed
Primidone	Primidone	22	suppressed
Propranolol Hcl	Propranolol Hcl	22	suppressed
Digoxin	Digoxin	21	suppressed
Nifedipine Er	Nifedipine	21	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	16
Pregabalin	Pregabalin	18	suppressed
Famotidine	Famotidine	17	suppressed
Fluconazole	Fluconazole	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Ondansetron Hcl	Ondansetron Hcl	17	suppressed
Estradiol	Estradiol	16	suppressed
Glipizide	Glipizide	16	suppressed
Levetiracetam	Levetiracetam	16	suppressed
Methotrexate	Methotrexate Sodium	16	suppressed
Sertraline Hcl	Sertraline Hcl	16	suppressed
Silver Sulfadiazine	Silver Sulfadiazine	16	13
Symbicort	Budesonide/Formoterol Fumarate	16	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	15	14
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	15	suppressed
Dropsafe Prep Pads	Alcohol Antiseptic Pads	15	suppressed
Farxiga	Dapagliflozin Propanediol	15	suppressed
Pravastatin Sodium	Pravastatin Sodium	15	suppressed
Ventolin Hfa	Albuterol Sulfate	15	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	14	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	14	suppressed
Labetalol Hcl	Labetalol Hcl	14	suppressed
Mirtazapine	Mirtazapine	14	suppressed
Risperidone	Risperidone	14	suppressed
Fentanyl	Fentanyl	13	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	13	suppressed
Methimazole	Methimazole	13	suppressed
Morphine Sulfate Er	Morphine Sulfate	13	suppressed
Ondansetron Odt	Ondansetron	13	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	13	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	12	suppressed
Eliquis	Apixaban	12	suppressed
Hydrocodone-Ibuprofen	Hydrocodone/Ibuprofen	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Novolin R	Insulin Regular, Human	12	suppressed
Oxcarbazepine	Oxcarbazepine	12	suppressed
Permethrin	Permethrin	12	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	12	suppressed
Clobazam	Clobazam	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Nystatin	Nystatin	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	11	suppressed
Terbinafine Hcl	Terbinafine Hcl	11	suppressed
Xarelto	Rivaroxaban	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$138.99 · 5 records	GENZYME CORPORATION	Belbuca, JOURNAVX, The Cologuard Plus Collection Kit	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error